AGF Management’s AstraZeneca AZN Stock Holding History

AGF Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$320K	Sell	1,622 -1	-0.1%	-$193	﹤0.01%	618
2025 Q4	$298K	Hold	1,623	–	–	﹤0.01%	628
2025 Q3	$249K	Hold	1,623	–	–	﹤0.01%	635
2025 Q2	$227K	Hold	1,623	–	–	﹤0.01%	616
2025 Q1	$239K	Hold	1,623	–	–	﹤0.01%	642
2024 Q4	$213K	Sell	1,623 -668,435	-100%	-$93.6M	﹤0.01%	677
2024 Q3	$104M	Buy	670,058 +18,278	+3%	+$2.95M	0.53%	58
2024 Q2	$102M	Buy	651,780 +253,233	+64%	+$38.1M	0.56%	57
2024 Q1	$54M	Buy	398,547 +32	+0%	+$4.24K	0.3%	103
2023 Q4	$53.7M	Buy	398,515 +5,709	+1%	+$742K	0.32%	103
2023 Q3	$53.2M	Buy	+392,806	New	+$53.6M	0.38%	94
2023 Q2	–	Sell	-712,954	Closed	-$99M	–	681
2023 Q1	$99M	Buy	712,954 +362,669	+104%	+$48.8M	0.68%	39
2022 Q4	$47.5M	Buy	+350,285	New	+$43.9M	0.34%	87

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

AGF Management's AZN Position: Q1 2026 in Review

AGF Management reduced its AstraZeneca (AZN) stake by 0.06% in Q1 2026, selling an estimated $193 and leaving 1,622 shares worth $320K. The position accounts for ﹤0.01% of the portfolio, ranked #618.

AGF Management first reported a position in AZN in Q4 2022 and has held it in 13 quarters since. The position peaked at $104M in Q3 2024. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

AGF Management held 1,622 shares of AstraZeneca worth $320K as of Q1 2026.
AGF Management sold 1 AstraZeneca share in Q1 2026, an estimated $193.
AstraZeneca made up ﹤0.01% of AGF Management's portfolio in Q1 2026, its #618 holding.
AGF Management first reported a position in AstraZeneca in Q4 2022 and has held it in 13 quarters since.
AGF Management's AstraZeneca position peaked at $104M in Q3 2024.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on AGF Management's 13F filing for Q1 2026, filed 7 May 2026.